Better Therapeutics, a prescription digital therapeutic startup, has launched AspyreRx, a cognitive behavioral therapy app to treat adults with type 2 diabetes. The app received FDA approval in July 2023 and is now available for download on the Apple Store and Google Play Stores.
AspyreRx aims to help patients make meaningful and sustainable behavioral changes to improve their diabetes management. During the initial launch phase, eligible patients can access AspyreRx on a cash-pay basis for a limited time through a smartphone and be prescribed for a 90-day treatment period for USD 750.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.